1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2.Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1Increasing understanding of drug metabolism per individual
4.1.2Requirement of controlled release of drugs
4.1.3 Increase in individual therapy
4.2 Restraints
4.2.1 Stability issues
4.2.2Stringent Regulatory Guidelines
4.2.3 Product Recalls
4.2.4 Competition
4.3 Opportunities
4.3.1 Patent Expiries of Blockbuster Drugs
4.4 Challenges
4.4.1High cost of development
5. The Middle East & Africa Novel Drug Delivery System Market -By Route of Administration
5.1 Transdermal Drug Delivery Systems
5.2 Pulmonary Drug Delivery Systems
5.3 Injectable Drug Delivery Systems
5.4 Oral Drug Delivery Systems
6. The Middle East & Africa Novel Drug Delivery System Market- By Country
6.1. Introduction
6.2.Middle East
6.3. Africa
7. Company Profiles
7.1 Genzyme Corporation
7.2 3M Company
7.3 Abbott Laboratories
7.4 Amgen Inc.
7.5 AstraZeneca PLC
7.6 Bausch & Lomb
7.7 Baxter International Inc.
7.8 Bayer Healthcare Pharmaceuticals
7.9 Boehringer Ingelheim
7.10 Boston Scientific
7.11 Bristol-Myers Squibb
7.12 Celgene Corporation
7.13 Cephalon, Inc.
7.14 Genentech Inc.
7.15 Generex Biotechnology Corporation
8. The Middle East & Africa Novel Drug Delivery System Market -Competitive Landscape
8.1 Market Share Analysis
8.2 Strategies Adopted by top companies
8.3 Mergers, Acquisitions, Collaborations & Agreements
9. Market Insights
9.1 Insights of Industry Experts
9.2 Investment Opportunities
9.3 Analyst Opinion
10. Appendix
10.1 List of Tables
10.2 List of Figures
